Introduction
Interleukin 6 (IL-6) is a multifunctional cytokine believed to be important in host defense, particularly in the initial response to infection or injury (reviewed in reference 1). induces the synthesis of acute phase proteins by hepatocytes (2) (3) (4) , stimulates immunoglobulin synthesis by B cells (5, 6) and differentiation of cytotoxic T cells (7, 8) , and induces both pluripotential hematopoetic progenitor cells to enter the cell cycle (9) and more committed progenitors to differentiate into granulocytes and macrophages (10, 11) . It is synthesized in response to a variety of stimuli, including viruses (12, 13) and other cytokines such as interleukin 1 and tumor necrosis factor (14, 15) , and appears in circulation in a number of febrile illnesses (16) (17) (18) .
There is considerable, although largely circumstantial, evidence implicating abnormal expression of IL-6 in a variety of disease states. IL-6 may function as an autocrine or paracrine growth factor in multiple myeloma (19, 20) , myeloid leukemia (21) , lymphoma (22) , and renal cell carcinoma (23) , and in nonneoplastic disorders such as psoriasis (24) and mesangial proliferative glomerulonephritis (25) . Synthesis of IL-6 by rheumatoid synovium (26) (27) (28) , by the germinal centers of hyperplastic lymph nodes in Castleman's disease (29) , and by certain tumors (30) suggests it may also have a role in producing the fever, hypergammaglobulinemia, and changes in acute phase proteins associated with these disorders.
To investigate the consequences of dysregulated synthesis of IL-6 in vivo, we constructed a high-titer retroviral vector bearing the murine IL-6 coding sequences and introduced the gene into hematopoietic cells of mice. Congenitally anemic W/WV mice transplanted with retrovirus-infected bone marrow cells developed a syndrome that closely resembles multicentric Castleman's disease.
Methods
Animals and cells. WBB6Fl W/WV and C57BL/6J mice were purchased from the Jackson Laboratory (Bar Harbor, ME). The IL-6-dependent murine plasmacytoma cell line T1 165 (31) was provided by Dr. Richard Nordan, and the 4-2 packaging line (32) was obtained from Dr. Richard Mulligan. The PA317 packaging cell line (33) was obtained from the American Type Culture Collection (Rockville, MD).
Construction of N2-IL6 vector and retrovirus producer line. The 1.6-kb Pst I-Nde I fragment of pCD-mIL6 (11) was ligated with the 2.7-kb Pst I-Nde I fragment ofpCD-IL3 (34) . The Xho I-Ssp I fragment of the resulting plasmid containing murine IL-6 coding sequences preceded by two SV40 splice acceptor sequences was subcloned into the polylinker of a modified pUC plasmid. A 1.1-kb Xho I-Sal I fragment of this intermediate construct was then subcloned into the Xho I cloning site of a plasmid containing the N2 retroviral vector (35) and the correct orientation selected. The resulting retroviral vector was designated N2-IL6 (Fig. 1). 4l-2 packaging cells were transfected using the calcium phosphate method (36) , and individual neomycin resistant (neoR)! clones were expanded after selection for 10 d in the neomycin analogue G418 at a concentration of 0.4 mg/ml active drug. To achieve a higher titer producer line, supernatant from the clone with the highest titer obtained by direct transfection (3 X 106 neoR U/ml) was used to infect the PA3 17 amphotropic packaging cell line. 48 h later, filtered supernatant was applied to 4P-2 cells and individual neomycin-resistant clones were selected in G418 as described. One ecotropic producer clone with a titer of 4 X 107 neoR U/ml was used for all gene transfer experiments.
Helper virus was detected only in undiluted supernatant (2 plaqueforming units/ml) using an S+ L-assay (37 Immunoglobulin analysis. Cellulose acetate electrophoresis and immunoelectrophoresis of serum and plasma samples were performed according to manufacturer's instructions (Helena Laboratories, Beaumont, TX). Immunoglobulin levels were measured with a radial immunodiffusion kit using the diffusion times recommended by the manufacturer (The Binding Site, San Diego, CA). Antiserum to immunoglobulin subclasses was obtained from Caltag Laboratories (South San Francisco, CA) and The Binding Site.
Nucleic acid analysis. High molecular weight DNA was obtained from mouse organs by digestion overnight at 550C in 50 mM Tris (pH 7.4), 100 mM EDTA, 100 mM sodium chloride, 1% SDS, and 2 mg/ml proteinase K. DNA was ethanol precipitated after phenol and chloroform extractions and resuspended in 10 mM Tris (pH 7.4), 1.0 mM EDTA. Restriction endonuclease digestion with Sst I, Bgl II, or Eco R1, agarose gel electrophoresis, and Southern blot analysis were performed using standard techniques (39). A 0.6-kb Bgl II-Nco I fragment of pRSVneo was used to probe for proviral sequences, and a 0.7 kb Xba I-Eco RI murine heavy chain joining probe was used to screen tissues for the presence of clonal immunoglobulin gene rearrangements. Total cellular RNA was obtained using the guanidine isothiocyanate/cesium chloride method (40) , and Northern blot analysis was carried out as described (39) using a 0.6-kb Pst I-BgJ II fragment of the murine IL-6 cDNA as probe. All (Fig. 2) . Southern blot analysis of DNA from peripheral blood (not shown) and spleen ( Fig. 2) ofthe primary animal revealed a more complex pattern, suggesting that more than one retrovirus-infected stem cell was contributing to hematopoiesis at the time it was killed.
Northern blot analysis revealed spliced retroviral transcripts of the expected lengths in RNA isolated from tissues infiltrated with plasma cells (Fig. 3) . The 2.2-kb species from which IL-6 protein is translated was found in lower abundance than the full-length genomic and other major spliced transcript, as was noted with a similarly constructed retrovirus bearing the coding sequences for murine IL-3 (42) . The level of retroviral RNA expression detected in Northern blot analysis correlated with the relative intensity of proviral bands in DNA analysis of corresponding tissues.
Using an assay for plasmacytoma growth factor activity, elevated levels of IL-6 were found in serum and plasma of animals receiving marrow infected with the N2-IL6 virus. Serum IL-6 activity ranged between 400 and 3,200 U/ml in animals studied 8 wk after transplant. This activity was completely inhibited by a rabbit polyclonal antiserum to murine IL-6 (data not shown). In contrast, IL-6 activity was not detected in any of the N2 controls. No direct relationship be- DNA from spleen of an affected animal and the indicated organs from a secondary recipient of bone marrow from this animal was digested with Sst I and Bgl II and subjected to Southern blot analysis using the 0.6-kb Bgl II-Nco I fragment of pRSVneo as a probe. Digestion with Sst I, which cuts within each long terminal repeat, gives a single band of the same size as the provirus. Bgl II cuts once within the provirus and gives a unique band for each proviral integrant. All tissues analyzed from this secondary recipient and another affected secondary recipient (not shown) contained four proviral integrants, with higher copy numbers seen in peripheral blood, bone marrow, and spleen than in lymph nodes and thymus. Additional proviral integrants were noted in spleen and peripheral blood of primary animal. Numbers represent sizes in kilobases of DNA markers.
tween circulating IL-6 activity and plasma IgG levels was noted.
IL-6 induces a polyclonal hypergammaglobulinemia with plasma cell hyperplasia. Cellulose acetate electrophoresis of plasma revealed a diffusely increased gamma globulin fraction, consistent with a polyclonal hypergammaglobulinemia, in the majority of animals transplanted with bone marrow cells infected with the N2-IL6 virus (Fig. 4 A) (Fig. 4 B) .
Postmortem examination revealed massive splenomegaly and peripheral lymph node enlargement. Multiple, enlarged cervical, axillary, subcutaneous, mesenteric, and inguinal nodes of up to 1 cm in size were seen, without significant mediastinal or retropentoneal adenopathy. Histological analysis showed almost complete replacement of nodes by mature plasma cells; the sinuses were dilated and follicles atretic ( was also noted. Smaller numbers ofplasma cells were also seen in kidney, portal zones of liver, and thymus. A pleomorphic infiltrate that included plasma cells and polymorphonuclear leukocytes was noted in the alveolar septae of lung.
Southern blot analysis was performed to verify the polyclonal nature ofthe plasma cell expansion in these animals. DNA was extracted from tissues rich in plasma cells, digested with Eco RI, and probed with a heavy chain joining region probe to detect immunoglobulin gene rearrangements. Only the 6.5-kb germline band, with no apparent oligoclonal or monoclonal immunoglobulin gene rearrangements, was noted (Fig. 6) virus also developed a hypochromic, microcytic anemia ( appeared enlarged, although not increased in number, compared to controls. Focal infiltrates of polymorphonuclear leukocytes were noted also in lymphoid tissues in all animals studied, with occasional megakaryocytes seen in several nodes from one animal. Storage iron was present in bone marrow.
Production of IL-6 appeared to have significant systemic effects. The majority of animals with the syndrome were inactive and many appeared dyspneic. Subcutaneous fat was markedly decreased, and most animals developed palpable splenomegaly. 5 of the first 14 IL-6 animals died within 15 wk and 3 had to be killed after 15-21 wk posttransplant. Marked hypoalbuminemia and hyperfibrinogenemia were noted on plasma protein electrophoresis (Fig. 4 A) . No evidence of amyloid deposits was found in Congo red-stained sections of bone marrow, liver, spleen, and heart.
In addition to the pathological changes produced in organs by plasma cell infiltration, glomerular enlargement, resulting from an increase in mesangial cells and matrix, was noted in stained sections of kidney (Fig. 9) . 
Discussion
We have found that deliberate dysregulation of IL-6 expression in mice produces a disorder nearly identical to multicentric Castleman's disease in humans. The original description of Castleman's disease was ofa solitary lymphoid mass that, typically, arises in the mediastinum and is cured with surgical excision (43) . A plasma cell variant that may be localized or multicentric has been more recently recognized (44) . Multicentric Castleman's disease is a systemic lymphoproliferative disorder characterized by the enlargement of multiple, preferentially peripheral, nodal groups, splenomegaly, hepatomegaly, and a variety of constitutional symptoms. Anemia and hypoalbuminemia were universal in one series (45) , and polyclonal hypergammaglobulinemia has been noted in most patients. Thrombocytopenia is characteristic, and transient neutrophilia has also been observed. The diagnostic pathological findings are in lymph nodes and include diffuse plasmacytosis and prominent germinal centers, with preservation of nodal architecture (46) . The clinical manifestations are often severe, and the disorder frequently proves fatal. Multicentric Castleman's disease has been considered to be a hyperplastic lymphoproliferative disorder of an idiopathic nature (44) . Recently, evidence for dysregulated IL-6 synthesis in both the localized and multicentric plasma cell forms has been provided by Kishimoto and colleagues (29) . They reported that the lymph nodes from two patients conditioned media with biologically active IL-6 and, based on immunocytochemical studies, concluded that cells in the germinal center were the likely source. Elevated serum levels of IL-6 were measured in both patients, and, in one patient with localized disease, removal of the hyperplastic node resulted in a decline in circulating IL-6 levels followed by resolution of clinical symptoms and normalization of laboratory values. Our data provide a direct test of their hypothesis that dysregulated synthesis of IL-6 has a causative role in this disorder.
The clinical, hematological, and gross pathological findings in mice transplanted with bone marrow cells infected with the IL-6 retrovirus are remarkably similar to those ofpatients with the multicentric form of Castleman's disease. Hypochromic, microcytic anemia, which may be severe, is a prominent feature in both. In one well-studied patient, the anemia was associated with hypoferremia, hypotransferrinemia, and increased storage iron in bone marrow (47) , typical of the anemia of chronic disease. Hematocrit, red cell morphology, and iron studies subsequently normalized, as did the immunologic abnormalities, after excision of a mediastinal mass. Although we have not studied iron metabolism in the mice in detail, storage iron was present in bone marrow, and it is likely the anemia has the same pathogenesis.
Transient granulocytosis was also seen in the mice and may have resulted from both stimulation of pluripotential progenitors to enter the cell cycle and differentiation of progenitors committed to granulocyte and macrophage formation. In cell culture, IL-6 has been shown to act synergistically with IL-3 to support the proliferation of multipotential hematopoietic progenitors (9, 48) and to have granulocyte-macrophage colony-stimulating activity (10, 1 1). The enlargement of megakaryocytes noted in mice that had received marrow transduced with the N2-IL6 virus is also consistent with the cytokine's actions in vitro (49) . Although i i i i s l 1 1 1 _ r . ! | ; mice (50), the IL-6 mice had lower platelet counts than concurrent controls, similar to patients with multicentric Castleman's disease, the majority of whom develop thrombocytopenia (45) .
One notable difference between the mice and patients is that the germinal centers, which are prominent in patients with the plasma cell forms of Castleman's disease (46) , are atretic in the hyperplastic lymph nodes of the mice. This may reflect the difference in the cell type secreting the cytokine. An abnormal cell in the germinal center, which may be a B lymphocyte (29) , is the apparent source of IL-6 in Castleman's disease, while a bone marrow-derived cell that repopulates lymph nodes and spleen is likely responsible for the accumulation of plasma cells in these locations in the mice. The common retroviral integration pattern seen in DNA from both hematopoietic and lymphoid tissues and in different recipients ofbone marrow from the same affected animal is indicative of retroviral infection of a hematopoietic stem cell. The presence of retroviral RNA species in organs infiltrated with plasma cells and extramedullary hematopoiesis in lymph nodes are in favor of local production of IL-6 by a bone marrow-derived cell.
Findings similar to those resulting from retrovirus-mediated transfer of murine IL-6 sequences have been noted in transgenic mice carrying the human IL-6 gene linked to the human immunoglobulin heavy chain enhancer (51) , although no hematologic data were reported. These mice also developed polyclonal hypergammaglobulinemia and diffuse plasmacytosis involving lymph nodes, spleen, and thymus. It is evident from Southern blot analysis, however, that many ofthe plasma cells in the mice generated by retroviral gene transfer must not contain the introduced gene, in contrast to the situation that exists in the transgenic mice. The retrovirus model thus more closely simulates Castleman's disease, in which paracrine stimulation of B cell proliferation and differentiation is thought to occur.
Although not detected in either type of mice, clonal immunoglobulin gene rearrangements have been noted in some (52) but not other (53) patients with multicentric Castleman's disease. A proportion of these patients ultimately develop monoclonal lymphoproliferative disorders, including multiple myeloma (44) , and it is possible that the altered expression of certain genes involved in cell growth is responsible for this neoplastic progression. Through the use of retrovirus-mediated gene transfer, it will be possible to test whether the enforced expression ofIL-6 together with candidate genes such as c-myc, believed to be important in the development ofplasmacytomas in pristane-injected mice (54) , is sufficient to produce a neoplastic disorder with a plasma cell phenotype.
